ライフサイエンスコーパス: hospital readmission

1 atisfaction and either major complication or hospital readmission.

2 ins were associated with hazard of all-cause hospital readmission.

3 Patients with ESRD are at high risk for hospital readmission.

4 y (SNF) performance measures and the risk of hospital readmission.

5 ications, is associated with a lower risk of hospital readmission.

6 as associated with less late NIV failure and hospital readmission.

7 a tipping point exists for LOS reduction and hospital readmission.

8 rate for the combined end point of death and hospital readmission.

9 ospital mortality, short-term mortality, and hospital readmission.

10 time, with higher risks of complications and hospital readmission.

11 cluding length of stay (LOS), mortality, and hospital readmission.

12 talization, nonroutine discharge status, and hospital readmission.

13 The primary outcome was 30-day unplanned hospital readmission.

14 p = 0.04) were independently associated with hospital readmission.

15 (83%) reporting greater than or equal to one hospital readmission.

16 minor complications, failure to rescue, and hospital readmission.

17 Heart failure (HF) is the leading cause for hospital readmission.

18 or patients who underwent surgery who needed hospital readmission.

19 ength of hospital stay and time to all-cause hospital readmission.

20 1.25]) were associated with a higher risk of hospital readmission.

21 ontributor to excess healthcare costs due to hospital readmissions.

22 alth care reform has been on reducing 30-day hospital readmissions.

23 postdischarge mortality related to reducing hospital readmissions.

24 and does not result in higher-than-expected hospital readmissions.

25 that this reduction may result in increased hospital readmissions.

26 vement on any variables except self-harm and hospital readmissions.

27 suicide attempts, and rates and duration of hospital readmissions.

28 lure trials, when compared with mortality or hospital readmissions.

29 h outcomes and a positive effect on reducing hospital readmissions.

30 n the usual care group, but no difference in hospital readmissions.

31 e events, overall serious adverse events, or hospital readmissions.

32 ortality (45 [2.0] vs 37 [1.6]; P = .23) and hospital readmissions (107 [4.9] vs 103 [4.4]; P = .42)

33 aths, 14 urgent transplant procedures during hospital readmission, 12 elective transplant procedures

34 ex admission (-$11 [95% CI, -$278 to $257]), hospital readmission ($245 [95% CI, -$231 to $721]), or

35 to hypotension (13% vs. 6%), or 30-day death/hospital readmission (33% vs. 25%).

36 % vs 5.7%, P = 0.001), and procedure-related hospital readmission (5.5% vs 8.0%, P = 0.03).

37 tations (10.8% v 13.8%; P = .2) or unplanned hospital readmissions (8.6% v 10.5%; P = .4) at 1 month.

38 6 months after referral, there were only 63 hospital readmissions (85% reduction), with 0.29/patient

39 Hospital readmission after colorectal surgery is common,

40 Hospital readmission after pancreatic resection is commo

41 es was associated with an increased risk for hospital readmission after pancreatoduodenectomy.

42 rd can be used to refine risk prediction for hospital readmission after percutaneous coronary interve

43 Early hospital readmission after transplantation is common and

44 k factors, outcomes, and prevention of early hospital readmissions after kidney, liver, and kidney-pa

45 We confirmed that the majority of unplanned hospital readmissions after sepsis are due to an infecti

46 dence suggests that some, but not all, early hospital readmissions after transplantation may be preve

47 ssion (DHR) data, they may underestimate all-hospital readmission (AHR) rates (hospital A to hospital

48 cations highlighting the high rates of early hospital readmissions among transplant recipients, more

49 poor and there are few treatments to prevent hospital readmission and death.

50 The coprimary outcomes were all-cause hospital readmission and emergency department visits (tr

51 tions, length of hospital stay, and rates of hospital readmission and emergency department visits wit

52 ics, comorbidities, CMV disease coded during hospital readmission and inpatient death.

53 Frailty increases early hospital readmission and mortality risk among kidney tra

54 Overall rates of hospital readmission and serious adverse events were sim

55 survivors were followed for 1 year to assess hospital readmission and survival.

56 ce of suboptimal care, such as high rates of hospital readmission and underuse of ACE inhibitors.

57 hospital system could save approximately 7.5 hospital readmissions and 253.8 hospital days per year.

58 tivariate modeling approach that categorizes hospital readmissions and emergency department visits as

59 fficient option when analyzing heart failure hospital readmissions and emergency department visits.

60 ct clinical outcomes, resulting in increased hospital readmissions and higher long-term costs.

61 laboratory, and imaging data with number of hospital readmissions and in-hospital days over the next

62 g this high-risk group may decrease frequent hospital readmissions and increase access to transplanta

63 Heart failure-related hospital readmissions and mortality are often outcomes i

64 rogram decreases chronic heart failure (CHF) hospital readmissions and mortality over a six-month per

65 of stroke, poor functional status, increased hospital readmissions and substantial cognitive dysfunct

66 The potential for preventing early hospital readmissions and the impact on patient outcomes

67 Outpatient commitment can work to reduce hospital readmissions and total hospital days when court

68 Fifty-one (13%) donors required hospital readmission, and 14 (4%) required 2 to 5 readmi

69 ed return to the operating room and need for hospital readmission, and 8 minor wound-related complica

70 We compared mortality, hospital readmission, and changes in functional status i

71 ney disease, conversion to chronic dialysis, hospital readmission, and long-term mortality.

72 stay, cost of hospitalization, incidence of hospital readmission, and mortality for patients who did

73 acceptable perioperative complication rates, hospital readmission, and mortality rates.

74 ing in high rates of clinical complications, hospital readmissions, and death.

75 its with respect to hypertension management, hospital readmissions, and diabetic glycemic control.

76 hour contact for patients, prior approval of hospital readmissions, and HBPC team participation in di

77 ed as 100-adherence rate), 30-day mortality, hospital readmissions, and Medicare spending across hosp

78 tal sign measurements, length of stay (LOS), hospital readmissions, and mortality.

79 h nonaffective psychotic disorders, reducing hospital readmissions approximately 72% and requiring 28

80 Causes for early hospital readmission are most commonly due to surgical,

81 Hospital readmissions are believed to be an indicator of

82 Hospital readmissions are common after major surgery, al

83 Hospital readmissions are common and costly and, in some

84 Hospital readmissions are common and costly, and no sing

85 Hospital readmissions are common, costly, and potentiall

86 We assessed the risk of hospital readmission at 1 year, including measures of lo

87 cubitril/valsartan (LCZ696) reduces rates of hospital readmission at 30-days following HF hospitaliza

88 with care, and caregiver burden and reduced hospital readmissions at 6 months, but it did not substi

89 recurrent bloodstream infections, and 30-day hospital readmissions, but the AST intervention group ha

90 to reduce the absolute probability of 30-day hospital readmission by 3.5% (95% confidence interval, 1

91 Different-hospital readmissions constituted 13.9% of 31,325 AHRs.

92 The estimated savings in hospital readmission costs after subtracting the initial

93 io = 0.56, 95% CI: 0.32, 0.96; p = 0.03) and hospital readmission costs of $7,515 less per patient.

94 The number of planned hospital readmissions defined by the readmission measure

95 Because hospitals lack different-hospital readmission (DHR) data, they may underestimate

96 r 14 years, suggesting that as LOS improved, hospital readmission did not increase.

97 Different-hospital readmissions differentially affect hospitals' p

98 We assessed mortality, hospital readmission, discharge to home, and logistic re

99 dministrative and clinical diagnoses for all hospital readmissions, discrepancy between planned readm

100 Five themes emerged as reasons cited for hospital readmission: distressing symptoms, unavoidable

101 Number of rejection episodes and hospital readmissions during the first posttransplantati

102 Early hospital readmission (EHR) after kidney transplantation

103 Early hospital readmission (EHR) is associated with increased

104 s studies investigating patients at risk for hospital readmissions focus on medical services and have

105 identification of patients at risk for early hospital readmission following KT may guide discharge pl

106 We calculated crude 30-day all-cause hospital readmissions following carotid revascularizatio

107 Five-year freedom from hospital readmission for CHF was 78%.

108 outcomes may be used to estimate the risk of hospital readmission for CHF.

109 hod for identifying an individual's risk for hospital readmission for congestive heart failure (CHF)

110 erapy was associated with increased rates of hospital readmission for diabetic complications traditio

111 ollow-up, all patients remain alive, without hospital readmission for heart failure and with New York

112 as recently been focused on the reduction of hospital readmissions for COPD exacerbations, health sys

113 Hospital readmissions for heart failure (HF) contribute

114 ar composite outcome was all-cause death and hospital readmissions for myocardial infarction, heart f

115 ice visits, emergency department visits, and hospital readmissions for newborns.

116 Reducing hospital readmissions for patients with heart failure is

117 ly implemented financial penalties to reduce hospital readmissions for select conditions, including c

118 In contrast, among nonpenalty hospitals, readmissions for target conditions declined s

119 in admission (treat-and-release encounters), hospital readmissions from any source, and a combined me

120 Hospital readmission has been increasingly targeted as a

121 BACKGROUND DATA: Hospital readmission has been increasingly targeted as a

122 Over the past 5 years, early hospital readmissions have become a national focus.

123 he United States, national efforts to reduce hospital readmissions have been enacted, including the a

124 Efforts to reduce hospital readmissions have focused primarily on improvin

125 , T patients had a significant lower rate of hospital readmission (hazard ratio: 0.64, p < 0.001) and

126 ent outcomes, with a 32% lower likelihood of hospital readmission if the first inpatient unit was an

127 omes including delayed graft function, early hospital readmission, immunosuppression intolerance, and

128 y determined predictors of early nonelective hospital readmission in 92 (49 women and 43 men) nutriti

129 plex (OR, 3.5; 95% CI, 2.1-6.1) CHD, and for hospital readmission in both CHD groups combined (OR, 3.

130 To compare treatment failure leading to hospital readmission in children with complicated append

131 Hospital readmission in patients with defibrillators red

132 ns, costs, and predictors of cardiac-related hospital readmission in patients with tiered-therapy imp

133 with heart failure (HF) are at high risk for hospital readmission in the first 30 days following HF h

134 onitoring by outpatient providers can reduce hospital readmissions in patients receiving hemodialysis

135 lease visits and 147.6 (95% CI, 147.3-147.9) hospital readmissions in the 30 days following discharge

136 Reducing hospital readmissions, including preventable healthcare-

137 ost data on readmission focus solely on same hospital readmission (index hospitals) within 30 days of

138 two regimens had similar toxicity profiles (hospital readmission, infection, wound complications, an

139 Early hospital readmission is a common and costly problem in t

140 Hospital readmission is a key marker of quality of healt

141 Early hospital readmission is also associated with decreased g

142 Hospital readmission is an important clinical outcome of

143 Early hospital readmission is an important metric for health c

144 This is important because hospital readmission is being used as a quality indicato

145 Hospital readmission is common after sepsis, yet the rel

146 Early hospital readmission is emerging as an indicator of care

147 One potential strategy for reducing early hospital readmissions is to critically examine care rece

148 A reduction in hospital readmissions may improve quality and reduce cos

149 ll, 10-year mortality was 98.8%, with 35 966 hospital readmissions occurring over the lifetime of the

150 Risk factors associated with early hospital readmission often reflect pretransplant comorbi

151 hospitalizations are frequently followed by hospital readmissions, often for recurrent sepsis.

152 that sustained outpatient commitment reduced hospital readmissions only when combined with a higher i

153 Hospital readmission or death occurred in 46% of patient

154 Independent factors influencing time to hospital readmission or death were identified.

155 The primary outcome was a composite of hospital readmission or death within 30 days of discharg

156 ber of diagnostic tests after infection, and hospital readmissions or visits to the emergency departm

157 nd age correlated with a lower likelihood of hospital readmission (OR = 0.94; P = 0.02).

158 Patients may experience multiple hospital readmissions over time with mortality acting as

159 alization had a significantly longer time to hospital readmission (P <.001) and improved survival (P

160 s of postoperative morbidity (P = 0.047) and hospital readmissions (P = 0.04) in the >/= 8 mug/mL com

161 9 readmissions/patient for control group) in hospital readmissions (P=.03) at 6 months that was not s

162 mpared with the worst-performing quartile of hospital readmission performance, there was a significan

163 Complicated PPS--noncomplicated PPS plus hospital readmission +/- pericardiocentesis or thoracent

164 le emergency department (ED) utilization and hospital readmissions pose a significant economic burden

165 Current approaches ascribe variability in hospital readmission primarily to differences in patient

166 The reduction in 30-day hospital readmission ranged from 0.5% to 4.9% in an addi

167 In a risk-adjusted hospital readmission rate analysis, hospitals that disch

168 interventions, from 2011 to 2015, the index hospital readmission rate has declined from 9.6% to 5.3%

169 Hospital readmission rate is receiving increasing regula

170 ned ED utilization rate was 11.3% and 30-day hospital readmission rate was 5.3%.

171 d hospital discharge within 23 hours, 30-day hospital readmission rate, early (<30 day) and late comp

172 functional status were associated with lower hospital readmission rates across the 6 impairment categ

173 Little risk-adjusted variation exists in hospital readmission rates after colorectal surgery.

174 rent efforts to improve health care focus on hospital readmission rates as a marker of quality and on

175 alth care systems, payers, and hospitals use hospital readmission rates as a measure of quality.

176 ospital-level variation among regional index hospital readmission rates as an instrument, instrumenta

177 Hospital readmission rates following surgery are increas

178 rvices (CMS) began publicly reporting 30-day hospital readmission rates for patients discharged with

179 Risk-standardized 30-day mortality and hospital readmission rates for pneumonia are increasingl

180 The 90-day hospital readmission rates for those with ABSSSIs may be

181 Reducing hospital readmission rates is a national priority; howev

182 is not associated with an increase in 30-day hospital readmission rates or wound complications when c

183 The release of the CMS public reporting of hospital readmission rates was not associated with any m

184 Hospital readmission rates were similar for those discha

185 Hospital readmission rates within 30 days after acute my

186 nia also had higher 30-day mortality, 30-day hospital readmission rates, and hospital spending per pa

187 red 1 mo after hospital discharge, including hospital readmission rates, health-related quality of li

188 ransplant recipients from the calculation of hospital readmission rates, the outcome of their advocac

189 al LOS that were accompanied by increases in hospital readmission rates.

190 spital mortality, discharge disposition, and hospital readmission rates.

191 Services recently started publicly reporting hospital readmission rates.

192 ion rates, discharge destination, and 30-day hospital readmission rates.

193 Patients with cirrhosis have high hospital readmissions rates but the relationship between

194 Reducing hospital-readmission rates is a clinical and policy prio

195 solate hospital effects on risk-standardized hospital-readmission rates, we examined readmission outc

196 For penalty hospitals, readmission rates for target conditions decli

197 was by telephone or review of outpatient or hospital readmission records.

198 and Medicaid Services (CMS) will expand its Hospital Readmission Reduction Program (HRRP) to include

199 ion rates declined after announcement of the Hospital Readmission Reduction Program (HRRP), which pen

200 To understand the impact of the Hospital Readmission Reduction Program on both future ta

201 o assess the rates of readmission before the Hospital Readmission Reduction Program was announced (20

202 The Hospital Readmission Reduction Program, established unde

203 ing to financial incentives announced in the Hospital Readmission Reduction Program.

204 icare's value-based purchasing (VBP) and the Hospital Readmissions Reduction Program (HRRP) could dis

205 st improvement after passage of the Medicare Hospital Readmissions Reduction Program (HRRP) is unknow

206 st improvement after passage of the Medicare Hospital Readmissions Reduction Program (HRRP) is unknow

207 pared using the CMS Hospital Compare and the Hospital Readmissions Reduction Program (HRRP) methodolo

208 es centers subject to the first cycle of the Hospital Readmissions Reduction Program between July 1,

209 al penalties were projected according to the Hospital Readmissions Reduction Program formula using on

210 The Hospital Readmissions Reduction Program penalizes hospit

211 S Centers for Medicare and Medicaid Services Hospital Readmissions Reduction Program penalizes hospit

212 The Hospital Readmissions Reduction Program will potentially

213 During the first cycle of the Hospital Readmissions Reduction Program, participating h

214 The Hospital Readmissions Reduction Program, which is includ

215 th above-average readmission rates under the Hospital Readmissions Reductions Program.

216 Hospital readmissions represent an important burden in t

217 Predicting hospital readmission risk is of great interest to identi

218 h November 30, 2009, to identify 30-day same-hospital readmissions (SHRs), DHRs, and AHRs.

219 Infection-related hospital readmissions, specifically, were more likely in

220 rce, and a combined measure of ED visits and hospital readmissions termed hospital-based acute care.

221 ong-term mortality, recurrent pneumonia, and hospital readmission, the few reported studies suggest t

222 Of the 315 hospital readmissions, the readmission diagnosis listed

223 This study examined predictors of hospital readmission to determine whether readmissions c

224 ondary outcomes were number of reoperations, hospital readmissions, total length of hospital stay dur

225 justed HR, 3.2; 95% CI, 1.3-7.8), and 30-day hospital readmission (unadjusted HR, 3.2; 95% CI, 2.0-5.

226 Assessment of 30 day same hospital readmissions underestimated the true incidence

227 nical medical record review, and fraction of hospital readmissions unrelated to the original hospital

228 dict readmission risk and explore sources of hospital readmission variation.

229 The rate of cardiac-related hospital readmission was 0.72 per patient-year of follow

230 nt for baseline characteristics, the rate of hospital readmission was 20.5% in women and 11.0% in men

231 Early hospital readmission was defined as readmission to hospi

232 The median length of stay for hospital readmissions was 5 days (interquartile range, 3

233 s hospitalized with CHF at increased risk of hospital readmission were randomized to a multidisciplin

234 rates, prolonged hospital stay, and rates of hospital readmission were significantly reduced.

235 vs. 59, 11%; P = 0.11), length of stay, and hospital readmission were similar in both groups.

236 Reoperations and hospital readmissions were adjudicated by independent re

237 cal site infection, anastomotic leakage, and hospital readmission when compared to no preoperative bo

238 gan dysfunction, mortality, reoperation, and hospital readmission, with estimated population attribut

239 ov 15, 2011, we assessed patients who needed hospital readmission within 30 days after open abdominal

240 Hospital readmissions within 30 days of discharge follow

241 ociated with emergency department visits and hospital readmissions within 30 days of discharge.

242 absolute rates of adverse outcomes, such as hospital readmission, worsening functional status, and w